Defective Medical Devices
Defective medical devices can cause injury and harm to unknowing patients. Medical device users expect treatments to work effectively and safely without undue risk or harm. Independent institutions, such as the Food and Drug Administration (FDA), place medical devices through extensive testing before releasing them to the consumer market. If potential risks and side effects are found, they are documented thoroughly and the user of the medical device is informed of any potential detriment to their health.
Regardless of this testing, medical devices are sometimes found to be faulty under certain circumstances or to raise the overall chance of illness or injury. The Guidant Defibrillator is one example of a defective medical device. Once installed, some models of the defibrillator run the risk of causing serious injury to the patient at an unknown time. Dealing with the risks associated with a defective medical device can have life-altering consequences.
In the event a defective medical device causes injury or death, the manufacturers of the device may be held legally liable for marketing a dangerous product. Some legal actions associated with defective medical devices evolve into class action or mass tort suits, whereby those affected by the hazardous devices can make a personal injury claim for a predetermined amount of compensation.
If you or a loved one has suffered an injury, illness, or death due to a defective medical device, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.
Defective Medical Devices
Links on the Web
 MedWatch Safety Alert RSS FeedFDA MedWatch Safety Alerts |
| Thu, 22 Jul 2010 00:00:00 -0400 Cook brand Ciaglia Blue Rhino/Ciaglia Blue Dolphin Percutaneous Tracheostomy Introducer Sets and Trays Recall due to balloon inflation assembly that may not hold air Click here to read this Defective Medical Devices news article. |
| Thu, 22 Jul 2010 00:00:00 -0400 Joyful Slim Herb Supplement : Recall-Undeclared Drug Ingredient Product contains sibutramine; may increase blood pressure/pulse rate with risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, stroke. Click here to read this Defective Medical Devices news article. |
| Tue, 20 Jul 2010 15:15:00 -0400 CONSTELLATION Vision System: Recall Software and hardware problems associated with unexpected system loss of power, unintended system error messages, unresponsive touchscreens, and system setting and infusion performance problems. Click here to read this Defective Medical Devices news article. |
| Tue, 20 Jul 2010 09:36:00 -0400 Vialipro Dietary Supplement: Recall-Undeclared Drug Ingredient Lab analyses found that certain batches of Vialipro contain Sulfoaildenafil, an analogue of Sildenafil. Click here to read this Defective Medical Devices news article. |
| Mon, 19 Jul 2010 08:32:00 -0400 Slim- 30 Herb Supplement: Undeclared Drug Ingredient Product found to contain undeclared N-Desmethyl Sibutramine and traces of Sibutramine. Click here to read this Defective Medical Devices news article. |
| Fri, 16 Jul 2010 14:10:00 -0400 Advair Diskus (fluticasone propionate and salmeterol inhalation powder): Stolen Product Warning Certain inhalers stolen from a distribution warehouse in 2009 have been found in some pharmacies. The safety and effectiveness of the stolen inhalers cannot be assured and they should not be used. Click here to read this Defective Medical Devices news article. |
| National Institutes of Health (NIH) News Releases News Releases from the National Institutes of Health (NIH) |
| Mon, 26 Jul 2010 12:03:00 EDT New Compound Improves Obesity-Related Health Complications in NIH-Led Study An experimental compound appears to improve metabolic abnormalities associated with obesity, according to a preliminary study led by researchers at the National Institutes of Health. A report of the study, which was conducted with obese mice, appears online today in the Journal of Clinical Investigation. Click here to read this Defective Medical Devices news article. |
| Thu, 22 Jul 2010 18:36:00 EDT NIH Director Announces Appointment of Alan Guttmacher as Director of NICHD National Institutes of Health Director Francis S. Collins M.D., Ph.D., announced today the appointment of Alan E. Guttmacher, M.D., as director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), one of the 27 institutes and centers that comprise the National Institutes of Health. The appointment follows an extensive national search. Click here to read this Defective Medical Devices news article. |
| Thu, 22 Jul 2010 16:16:00 EDT Scientists Identify Brain Circuits Related to the Initiation and Termination of Movement Sequences in NIH-Supported Study In humans, throwing a ball, typing on a keyboard, or engaging in most other physical activities involves the coordination of numerous discrete movements that are organized as action sequences. Scientists at the National Institutes of Health and the Gulbenkian Institute in Portugal have identified brain activity in mice that can signal the initiation and termination of newly learned action sequences. The findings appear online today in the current issue of Nature. Click here to read this Defective Medical Devices news article. |
| Thu, 22 Jul 2010 16:16:00 EDT Hyperthermia: Too Hot for Your Health Hot summer weather can pose special health risks to older adults. The National Institute on Aging (NIA), part of the National Institutes of Health, has some advice for helping older people avoid heat-related illnesses, known as hyperthermia. Click here to read this Defective Medical Devices news article. |
| Thu, 22 Jul 2010 09:16:00 EDT NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the French National Agency for Research on AIDS and Viral Hepatitis, brings physicians closer to optimizing the treatment of severely immunosuppressed individuals with HIV-TB co-infection. The findings were presented today at the XVIII International AIDS Conference in Vienna by principal investigators Francois-Xavier Blanc, M.D., Anne E. Goldfeld, M.D., and Sok Thim, M.D. Click here to read this Defective Medical Devices news article. |
| Wed, 21 Jul 2010 12:56:00 EDT NIHSeniorHealth Site Offers Tips on Creating a Family Health History At your next family reunion or gathering, consider discussing a different type of family tree--the family health history. Find out how to collect, organize and use information about your family's health at Creating a Family Health History, the newest topic on the NIHSeniorHealth website. NIHSeniorHealth is a health and wellness website designed especially for older adults from the National Institute on Aging (NIA) and the National Library of Medicine (NLM), both part of the National Institutes of Health. Click here to read this Defective Medical Devices news article. |
